Cargando…
Serum fibroblast growth factor 19 (FGF19) levels are associated with atherogenic dyslipidemia in patients with type 2 diabetes
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8478367/ https://www.ncbi.nlm.nih.gov/pubmed/34475326 http://dx.doi.org/10.1097/CM9.0000000000001574 |
| _version_ | 1784576040748711936 |
|---|---|
| author | Hu, Jing-Yi Zou, Hai-Lan Li, Yan-Hua Nie, Dong-Ying Chao, Chen Liu, Jin-Han Ding, Jin Zhou, Zhi-Guang Xiao, Yang |
| author_facet | Hu, Jing-Yi Zou, Hai-Lan Li, Yan-Hua Nie, Dong-Ying Chao, Chen Liu, Jin-Han Ding, Jin Zhou, Zhi-Guang Xiao, Yang |
| author_sort | Hu, Jing-Yi |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8478367 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-84783672021-09-30 Serum fibroblast growth factor 19 (FGF19) levels are associated with atherogenic dyslipidemia in patients with type 2 diabetes Hu, Jing-Yi Zou, Hai-Lan Li, Yan-Hua Nie, Dong-Ying Chao, Chen Liu, Jin-Han Ding, Jin Zhou, Zhi-Guang Xiao, Yang Chin Med J (Engl) Correspondence Lippincott Williams & Wilkins 2021-09-20 2021-09-01 /pmc/articles/PMC8478367/ /pubmed/34475326 http://dx.doi.org/10.1097/CM9.0000000000001574 Text en Copyright © 2021 The Chinese Medical Association, produced by Wolters Kluwer, Inc. under the CC-BY-NC-ND license. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) |
| spellingShingle | Correspondence Hu, Jing-Yi Zou, Hai-Lan Li, Yan-Hua Nie, Dong-Ying Chao, Chen Liu, Jin-Han Ding, Jin Zhou, Zhi-Guang Xiao, Yang Serum fibroblast growth factor 19 (FGF19) levels are associated with atherogenic dyslipidemia in patients with type 2 diabetes |
| title | Serum fibroblast growth factor 19 (FGF19) levels are associated with atherogenic dyslipidemia in patients with type 2 diabetes |
| title_full | Serum fibroblast growth factor 19 (FGF19) levels are associated with atherogenic dyslipidemia in patients with type 2 diabetes |
| title_fullStr | Serum fibroblast growth factor 19 (FGF19) levels are associated with atherogenic dyslipidemia in patients with type 2 diabetes |
| title_full_unstemmed | Serum fibroblast growth factor 19 (FGF19) levels are associated with atherogenic dyslipidemia in patients with type 2 diabetes |
| title_short | Serum fibroblast growth factor 19 (FGF19) levels are associated with atherogenic dyslipidemia in patients with type 2 diabetes |
| title_sort | serum fibroblast growth factor 19 (fgf19) levels are associated with atherogenic dyslipidemia in patients with type 2 diabetes |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8478367/ https://www.ncbi.nlm.nih.gov/pubmed/34475326 http://dx.doi.org/10.1097/CM9.0000000000001574 |
| work_keys_str_mv | AT hujingyi serumfibroblastgrowthfactor19fgf19levelsareassociatedwithatherogenicdyslipidemiainpatientswithtype2diabetes AT zouhailan serumfibroblastgrowthfactor19fgf19levelsareassociatedwithatherogenicdyslipidemiainpatientswithtype2diabetes AT liyanhua serumfibroblastgrowthfactor19fgf19levelsareassociatedwithatherogenicdyslipidemiainpatientswithtype2diabetes AT niedongying serumfibroblastgrowthfactor19fgf19levelsareassociatedwithatherogenicdyslipidemiainpatientswithtype2diabetes AT chaochen serumfibroblastgrowthfactor19fgf19levelsareassociatedwithatherogenicdyslipidemiainpatientswithtype2diabetes AT liujinhan serumfibroblastgrowthfactor19fgf19levelsareassociatedwithatherogenicdyslipidemiainpatientswithtype2diabetes AT dingjin serumfibroblastgrowthfactor19fgf19levelsareassociatedwithatherogenicdyslipidemiainpatientswithtype2diabetes AT zhouzhiguang serumfibroblastgrowthfactor19fgf19levelsareassociatedwithatherogenicdyslipidemiainpatientswithtype2diabetes AT xiaoyang serumfibroblastgrowthfactor19fgf19levelsareassociatedwithatherogenicdyslipidemiainpatientswithtype2diabetes |